Clinical Trials on Patients Requiring Home Parenteral Nutrition in Austria

Total 15 results

Melbourne Health

Recruiting

Contactless Vital Signs Measurement Study (CVMS) (CVMS)

Vital Signs | Inpatients | Hospital-at-home

Australia
Fresenius Kabi

Completed

Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition

Parenteral Nutrition

Australia, Denmark, France, Israel, Netherlands, Poland, United Kingdom
Medical University of Vienna

Completed

Perioperative Fluid Management in Patients Receiving Cadaveric Renal Transplants

Metabolic Acidosis | Hyperkalaemia Requiring Postoperative Dialysis

Austria
ClinTrio Ltd.

Unknown

Banded Versus Conventional Laparoscopic Roux-en-Y (GABY) (GABY)

Morbid Obesity Requiring Bariatric Surgery

Belgium, Germany, Portugal, Austria, Netherlands, Poland, Saudi Arabia
Medical University of Vienna

Completed

FGF-23 and PTH in Hemodialysis Patients

Chronic Kidney Disease Requiring Chronic Dialysis

Austria
Medical University of Graz

Completed

Clinical Risk Assesment of CS-1 Decision Support System

Hyperglycemia | Critically Ill Patients

Austria
Medical University of Graz

Completed

Tight Glycemic Control by eMPC Algorithm in Medical ICU Patients.

Hyperglycemia | Critically Ill Patients | Mechanical Ventilation

Austria
Ikaria Bioscience Pty Ltd

Recruiting

Adult Subjects With Elevated Low-Density Lipoprotein-Cholesterol to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects

To Reduce the LDL-C Level in Hypercholesteremia Adult Patients | Combination for Subgroup High LDL-c Patients With Other Comorbidities

Australia
Vifor Pharma
Fresenius Medical Care North America

Completed

A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients

Chronic Kidney Disease Requiring Chronic Dialysis

Latvia, United States, Belgium, Croatia, Austria, Czech Republic, Germany, Lithuania, Poland, Romania, Russian Federation, Serbia, South Africa, Ukraine, United Kingdom
Vifor Pharma
Fresenius Medical Care North America

Completed

A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients

Chronic Kidney Disease Requiring Chronic Dialysis

Latvia, United States, South Africa, Belgium, Croatia, Germany, Poland, Romania, Serbia, Ukraine, United Kingdom, Austria, Czech Republic, Lithuania, Russian Federation
Helsinn Healthcare SA

Withdrawn

Evaluation of the Effects of a Mixture of Amino Acids (Amixea) on Lean Body Mass and Muscle Strengh of Patients With Unresectable Advanced Non-small Cell Lung Cancer

Cancer Patients With Cachexia

Australia
Klinikum Floridsdorf
Medical University of Vienna; Klinik Favoriten; Salzkammergut Klinikum Vöcklabruck

Completed

BMI and Lymph Node Count in Colorectal Cancer

The Aim of This Study is to Determine the Influence of BMI and Lymph Node Status on OS in CRC Patients in the Long Term

Austria
Solvay Pharmaceuticals

Completed

A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes

Patients With Type 2 Diabetes

Australia
Novartis Pharmaceuticals

Completed

Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis (SBR759)

Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy

Germany, United Kingdom, Italy, Belgium, Sweden, Canada, United States, Australia, Finland, France, Norway, Puerto Rico, Switzerland
BioMarin Pharmaceutical

Terminated

A Prospective, Noninterventional, Observational Study of Late-Onset Pompe Disease

Late-onset Pompe Patients Untreated or Treated With rhGAA

Spain, Slovenia, Serbia, Korea, Republic of, Greece, Australia, Singapore, Brazil, Canada, Taiwan, Ireland, Poland, Romania

Clinical Trials on Patients Requiring Home Parenteral Nutrition in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations